Virus inactivated dried plasma - EntegrionAlternative Names: Resusix
Latest Information Update: 17 May 2016
At a glance
- Originator Entegrion
- Developer Entegrion; Kedrion
- Class Blood products and substitutes
- Mechanism of Action Blood coagulation factor stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Haemorrhage
Most Recent Events
- 15 Mar 2016 Biomarkers information updated